QuVa Pharma, Inc.: Drug Recall
Recall #D-1544-2022 · 09/20/2022
Class III: Low Risk
Recall Details
- Recall Number
- D-1544-2022
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- QuVa Pharma, Inc.
- Status
- Terminated
- Date Initiated
- 09/20/2022
- Location
- Bloomsbury, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1994 bags
Reason for Recall
Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).
Product Description
oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a Compounded Product for Institutional or Office Use Only, Not for Resale, QuVa PHARMA 519 Route 173, Bloomsbury, NJ 08804, Total volume: 500 mL bag, NDC: 70092-1068-07.
Distribution Pattern
Nationwide in the USA
Other Recalls by QuVa Pharma, Inc.
- Class II: Risk 10/10/2025
- Class II: Risk 03/06/2025
- Class II: Risk 03/06/2025
- Class II: Risk 03/06/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.